Mount Sinai Medical Center has opened the doors of its new Irma and Norman Braman Comprehensive Cancer Center, a five-story, 216,000-square-foot oncology hub on Biscayne Bay that more than triples the hospital’s cancer care capacity and reshapes the cancer care map in South Florida. The facility began receiving patients this week, marking the completion of one of the largest healthcare construction projects in Miami Beach in recent years.
The opening positions Miami Beach as a stronger regional hub for oncology care, on a campus already recognized for its cardiovascular and neurological specialty work. For patients across Miami-Dade and the broader South Florida region, it means consolidated access to diagnostics, treatment, research, and supportive services within a single, purpose-built environment.
A Facility Built for the Full Arc of Cancer Care
The Braman Comprehensive Cancer Center is designed to handle the full continuum of oncology care in one location. Inside the new building, Mount Sinai has installed 39 infusion bays for chemotherapy and other infusion-based treatments, along with 56 physician exam rooms. Two linear accelerators, used for precision radiation therapy, are operational at launch, with infrastructure in place for a third as patient demand grows.
An integrated diagnostic suite within the building allows imaging, laboratory work, and consultations to be coordinated under one roof, a model that cancer specialists increasingly view as the standard for high-volume comprehensive centers. The goal is to shorten the lag between diagnosis and treatment, a window that often determines outcomes in oncology and that has historically been one of the most stressful stretches for patients and families.
More Than a Treatment Center
The new facility is not solely a clinical operation. The building also houses an expanded breast center, the RAD Center for cancer genetics, dedicated clinical research space, and supportive care services for patients and their families.
The genetics component is especially notable. Cancer care has shifted in the past decade toward precision approaches that account for the genetic profile of both the patient and the tumor. The RAD Center positions Mount Sinai to expand its capacity in inherited cancer risk evaluation, biomarker-driven treatment decisions, and the kind of clinical trials that increasingly form the backbone of advanced oncology programs.
The clinical research footprint is significant for South Florida specifically. Trial access has historically been concentrated in a handful of academic medical centers nationwide, and the addition of dedicated research space at a major Miami hospital broadens access for patients who might otherwise have to travel to Houston, New York, or other research hubs to participate.
Supportive care services, including counseling, nutrition guidance, and family resources, round out the building. Cancer patients and their families have long described the logistical and emotional load of treatment as one of the hardest parts of the journey, and the integration of these services with clinical care reflects a broader shift in how comprehensive cancer centers are designed.
Tripling Capacity in a Growing Region
The expansion answers a clear regional need. South Florida’s population has grown steadily over the past decade, and Miami-Dade in particular has become a destination for older adults, who experience higher rates of cancer diagnosis. Tripling Mount Sinai’s cancer care capacity gives the hospital room to grow with the region rather than turn patients away or push wait times further out.
The capacity increase also reduces pressure on other regional cancer providers, particularly during peak treatment seasons. South Florida cancer centers, including UHealth’s Sylvester Comprehensive Cancer Center, have seen growing demand, and the addition of the Braman center adds meaningful regional capacity without duplicating the same model.
UHealth’s Sylvester Comprehensive Cancer Center has separately spent more than six years adapting radiation therapy from a verification step into an active treatment tool, according to Miami Today, signaling broader investment across the region in advanced radiation oncology.
Anchored on Biscayne Bay
The location on Biscayne Bay is not incidental. Mount Sinai’s main campus sits on a waterfront site that has been steadily redeveloped over the past several years, with new clinical and research facilities replacing older infrastructure. The Braman center continues that pattern, integrating into a campus that has become one of the most identifiable healthcare environments in Miami.
The waterfront setting also matters from a patient-experience perspective. Cancer treatment can stretch over months, sometimes years, and the design of treatment environments has become a recognized factor in how patients tolerate care. Natural light, water views, and architectural openness, hallmarks of the new building, align with current thinking on how oncology spaces can support recovery alongside clinical performance.
What It Means for Miami Beach
For Miami Beach, the opening reinforces a strategic position the city has been building for years: a destination not just for tourism, but for specialty medicine that draws patients from across the Caribbean, Latin America, and the southeastern United States. Mount Sinai’s cardiovascular and neurological programs have long been part of that draw. The Braman Comprehensive Cancer Center adds a third major pillar.
Cancer care is increasingly defined by access, integration, and research depth. With its expanded capacity, integrated services, and dedicated research footprint, the new facility gives Miami Beach a serious answer on all three measures, and gives South Florida patients a substantially shorter path between diagnosis and treatment.
For now, the doors are open. The harder, slower work of treatment, research, and recovery continues inside.
